(8R,9R,10S,13S,14S)-3-hydroxy-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-17-one
- $120 - $952
- Product name: (8R,9R,10S,13S,14S)-3-hydroxy-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-17-one
- CAS: 1225-01-0
- MF: C18H28O2
- MW: 276.41
- EINECS:
- MDL Number:
- Synonyms:(8R,9R,10S,13S,14S)-3-hydroxy-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-17-one;(3R,5S,8R,9R,10S,13S,14S)-3-hydroxy-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-17-one;19-Norandrosterone (1.0 mg/ml in Methanol);Rocuronium Bromide Impurity 55;Meropenem Impurity 37-d6;5α-ESTRAN-3α-OL-17-ONE
3 prices
Selected condition:
Brand
- Cayman Chemical
Package
- 1mg
- 5mg
- 10mg
- ManufacturerCayman Chemical
- Product number22683
- Product description19-Norandrosterone ≥98%
- Packaging1mg
- Price$120
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number22683
- Product description19-Norandrosterone ≥98%
- Packaging5mg
- Price$537
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number22683
- Product description19-Norandrosterone ≥98%
- Packaging10mg
- Price$952
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Cayman Chemical | 22683 | 19-Norandrosterone ≥98% | 1mg | $120 | 2024-03-01 | Buy |
Cayman Chemical | 22683 | 19-Norandrosterone ≥98% | 5mg | $537 | 2024-03-01 | Buy |
Cayman Chemical | 22683 | 19-Norandrosterone ≥98% | 10mg | $952 | 2024-03-01 | Buy |
Properties
solubility :Acetonitrile: 1 mg/ml; Ethanol: 1 mg/ml; Methanol: 1 mg/ml
form :A crystalline solid
form :A crystalline solid
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|